Constructive Bio, a pioneering synthetic genomics company, has secured £43 million in the first close of its Series A financing. The round was led by Ahren, OMX Ventures and Paladin Capital Group with participation from Fine Structure Ventures, +ND Capital and Abcam-founder Jonathan Milner. It brings the total amount raised by the company to date … Continue reading Constructive Bio raises £43m ‘to turn living cells into biofactories’